20160128 EGA Regulatory and Scientific Affairs Conferenc

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access / 31 May 2016 17:30 – 19:30, European Parliament

4 May 2016


10 Years of Biosimilar Medicines: Transforming Healthcare

28 April 2016

Biosimilar medicines provide an opportunity to increase patient access to […]

Read more

The European Parliament Calls on the Commission to Boost Manufacturing and Export of EU Generic and Biosimilar Medicines

21 April 2016

Launched on 28 October 2015 , the European Commission’s new […]

Read more

6 out of 10 Doctors Have Already Prescribed Biosimilar Medicines, According to EuropaBio Paper

20 April 2016

Medicines for Europe and its Biosimilar Medicines Group took note […]

Read more

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

Read more

100% increase in Patient Access to Biologic Treatments thanks to Biosimilar Medicines

30 March 2016

Biosimilar medicines represent an essential opportunity to optimise patient access to […]

Read more

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Read more

IGBA calls for full transparency and new timelines for impact assessment with regard to the voluntary WHO biological qualifier (BQ) proposal

2 March 2016


Medicines for Europe: Better Access, Better Health

1 March 2016


EGA Prioritises Pursuing Sustainability Agreements

12 February 2016


Subscribe to our newsletter